Clinical Trial

Long-term Surgical Treatment Outcome of Peri-implantitis Lesions

Recruiting
View on ClinicalTrials.gov →
Summary
The surgical treatment outcome of patients that have been or are consecutively treated at the University of Malmö, at Blekinge hospital, and at the Dental Clinic of the Sigmund Freud University Vienna will be evaluated on an a regular base; specifically all patients treated since 2014 and those receiving treatment in the future, will be regularly assessed, max. once per year after the 1-year control from the surgical intervention for clinical and radiographic assessment of healing. Clinical peri-implant parameters (e.g., probing pocket depth) and peri-implant sulcus fluid (PISF) are collected, and a peri-apical radiographic examination is made. Further, from 200 patients treated in the future, the inflammatory peri-implant lesion will be collected and subjected to histological, microbiological, and molecular analysis. The removal of these lesions is a standard procedure and performed in all patients independent of study participation; i.e., the lesion has anyway to be removed during surgery and if the lesions are not stored, they would be thrown.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-04-15; most recent amendment 2024-02-15.
Trial Details
NCT Number NCT05339789
Lead Sponsor Malmö University
Collaborators: Medical University of Vienna, Sigmund Freud PrivatUniversitat, Blekinge County Council Hospital
Conditions Peri-Implantitis
Enrollment 650 participants
Start Date 2020-08-30
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-02-16